Skip to main content
Contact Us
Subscribe
E-Edition
80°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Acasti Pharma
(NQ:
ACST
)
3.110
+0.110 (+3.67%)
Streaming Delayed Price
Updated: 3:55 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Acasti Pharma
< Previous
1
2
3
Next >
Stocks That Hit 52-Week Lows On Monday
November 14, 2022
Monday saw 33 companies set new 52-week lows.
Via
Benzinga
Acasti Pharma Reports Second Quarter 2023 Operational Results
November 14, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Acasti Pharma to Present at Q4 Investor Summit
November 09, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Recap: Acasti Pharma Q4 Earnings
June 21, 2022
Acasti Pharma (NASDAQ:ACST) reported its Q4 earnings results on Tuesday, June 21, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine
May 18, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
November 11, 2022
On Friday, 63 stocks hit new 52-week lows.
Via
Benzinga
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
November 07, 2022
Call to be held on Monday, November 14th at 1:00 PM Eastern Time
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Acasti Pharma Inc. (NASDAQ:ACST) (TSX.V:ACST) Featured in Coverage of Investor Summit Group’s Q4 Event
November 04, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Acasti Announces Court Dismissal of Stockholder Litigation
September 30, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
September 29, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Acasti Pharma Inc. Discusses Clinical Progress of Lead Assets and 2022 Catalysts with The Stock Day Podcast
September 21, 2022
Phoenix, Arizona--(Newsfile Corp. - September 21, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),...
Via
Newsfile
Exposures
Product Safety
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia
July 27, 2022
From
Acasti Pharma, Inc.
Via
GlobeNewswire
Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast
July 07, 2022
Phoenix, Arizona--(Newsfile Corp. - July 7, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),...
Via
Newsfile
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For June 21, 2022
June 21, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its first quarter.
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact
May 18, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
May 16, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public...
From
MicroCap Rodeo
Via
AccessWire
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th
May 12, 2022
LAVAL, QC / ACCESSWIRE / May 12, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST)(TSXV:ACST), today announced that Jan D'Alvise, Chief Executive Officer, has been invited to present...
From
Acasti Pharma Inc.
Via
AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
May 09, 2022
Good morning, trader! We're starting off another week of trading with an overview of the biggest pre-market stock mover for Monday!
Via
InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
May 09, 2022
Gainers Decisionpoint Systems, Inc. (NASDAQ: DPSI) shares rose 32.3% to $8.85 in pre-market trading after declining over 4% on Friday.
Via
Benzinga
Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast
February 22, 2022
Phoenix, Arizona--(Newsfile Corp. - February 22, 2022) - The Stock Day Podcast welcomed Acasti Pharma Inc. (NASDAQ: ACST) ("the Company"),...
Via
Newsfile
Acasti Pharma's Earnings Outlook
February 11, 2022
Acasti Pharma (NASDAQ:ACST) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Acasti Pharma...
Via
Benzinga
Acasti Pharma: Bouncing Back With a New Drug Pipeline
January 04, 2022
Picture credit: Louis Reed on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
December 23, 2021
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....
Via
Benzinga
Earnings Scheduled For February 14, 2022
February 14, 2022
Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.
Via
Benzinga
BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today
December 23, 2021
i3 Interactive (BLITF) stock is rising higher on heavy trading Thursday despite a lack of news from the mobile gambling company.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 23, 2021
Good morning, trader! Christmas is almost here but were aren't slowing down as we dive into the biggest pre-market stock movers for Thursday!
Via
InvestorPlace
54 Biggest Movers From Thursday
December 27, 2021
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...
Via
Benzinga
18 Stocks Moving in Thursday's Pre-Market Session
December 23, 2021
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) rose 26.5% to $1.86 in pre-market trading. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.